Corneal Absorption of a New Riboflavin-Nanostructured System for Transepithelial Collagen Cross-Linking

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Bottos, Katia M ^a   Oliveira, Anselmo G ^b   Bersanetti, Patrícia A ^a   Nogueira, Regina F ^a   Lima Filho, Acácio A S ^a   Cardillo, José A ^a   Schor, Paulo ^a   Chamon, Wallace ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; FLAVINE MONONUCLEOTIDE; PHOSPHATIDYLCHOLINE; POLYSORBATE 20;

ANIMAL TISSUE; ARTICLE; CENTRAL CORNEAL THICKNESS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA STROMA; DRUG ABSORPTION; DRUG DIFFUSION; DRUG PENETRATION; DRUG STABILITY; HYDROPHOBICITY; LONG TERM EXPOSURE; NANOEMULSION; NANOPHARMACEUTICS; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN CROSS LINKING; RABBIT; ZETA POTENTIAL;

ABSORPTION; ANIMALS; COLLAGEN; CORNEA; DRUG STABILITY; EMULSIONS; EPITHELIUM, CORNEAL; FLAVIN MONONUCLEOTIDE; KERATOCONUS; NANOSTRUCTURES; RABBITS; RIBOFLAVIN; TIME FACTORS;

ORYCTOLAGUS CUNICULUS;

EID: 84879942078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066408     Document Type: Article

References (42)

1. Wollensak G, Spoerl E, Seiler T, (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135: 620-627.
2. Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, et al. (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49: 3402-3408.
3. Jankov MR 2nd, Hafezi F, Beko M, Ignjatovic Z, Djurovic B, et al. (2008) Corneal Cross-linking for the treatment of keratoconus: preliminary results. Arq Bras Oftalmol 71: 813-818.
4. Bottos KM, Schor P, Dreyfuss JL, Nader HB, Chamon W, (2011) Effect of corneal epithelium on ultraviolet-A and riboflavin absorption. Arq Bras Oftalmol 74: 348-351.
5. Bottos KM, Dreyfuss JL, Regatieri CV, Lima-Filho AA, Schor P, et al. (2008) Immunofluorescence confocal microscopy of porcine corneas following collagen cross-linking treatment with riboflavin and ultraviolet A. J Refract Surg 24: 715-719.
6. Samaras K, O'Brart D P, Doutch J, Hayes S, Marshall J, et al. (2009) Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg 25: 771-775.
7. Hayes S, O'Brart DP, Lamdin LS, Doutch J, Samaras K, et al. (2008) Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg 34: 657-661.
8. Wollensak G, Iomdina E, (2009) Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg 35: 540-546.
9. Leccisotti A, Islam T, (2010) Transepithelial corneal collagen cross-linking in keratoconus. J Refract Surg 26: 942-948.
10. Baiocchi S, Mazzotta C, Cerretani D, Caporossi T, Caporossi A, (2009) Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg 35: 893-899.
11. Wollensak G, Aurich H, Wirbelauer C, Sel S, (2010) Significance of the riboflavin film in corneal collagen crosslinking. J Cataract Refract Surg 36: 114-120.
12. Kymionis GD, Bouzoukis DI, Diakonis VF, Portaliou DM, Pallikaris AI, et al. (2007) Diffuse lamellar keratitis after corneal crosslinking in a patient with post-laser in situ keratomileusis corneal ectasia. J Cataract Refract Surg 33: 2135-2137.
13. Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, et al. (2007) Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 33: 1982-1984.
14. Pollhammer M, Cursiefen C, (2009) Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg 35: 588-589.
15. Rama P, Di Matteo F, Matuska S, Paganoni G, Spinelli A, (2009) Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 35: 788-791.
16. Zamora KV, Males JJ, (2009) Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea 28: 474-476.
17. Chan CC, Sharma M, Wachler BS, (2007) Effect of inferior-segment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg 33: 75-80.
18. Kim JR, Oh TH, Kim HS, (2011) Effects of benzalkonium chloride on the ocular surface of the rabbit. Jpn J Ophthalmol 55: 283-293.
19. Ammar DA, Noecker RJ, Kahook MY, (2010) Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 27: 837-845.
20. Shigeyasu C, Shimazaki J, (2012) Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions. Cornea 31: 59-65.
21. Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, et al. (2012) Corneal Neurotoxicity Due to Topical Benzalkonium Chloride. Invest Ophthalmol Vis Sci 53: 1792-1802.
22. Koppen C, Gobin L, Tassignon MJ, (2010) The absorption characteristics of the human cornea in ultraviolet-a crosslinking. Eye Contact Lens 36: 77-80.
23. Krueger RR, Ramos-Esteban JC, Kanellopoulos AJ, (2008) Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy: laboratory investigation and first clinical case. J Refract Surg 24: 730-736.
24. Kanellopoulos AJ, (2009) Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg 25: 1034-1037.
25. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Paradiso AL, (2012) Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis. Eur J Ophthalmol 22: 81-88.
26. Morrison PW, Connon CJ, Khutoryanskiy VV, (2013) Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharm 10: 756-762.
27. Zhang Y, Sukthankar P, Tomich JM, Conrad GW, (2012) Effect of the Synthetic NC-1059 Peptide on Diffusion of Riboflavin across an Intact Corneal Epithelium. Invest Ophthalmol Vis Sci 53: 2620-2629.
28. Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM, (2006) Nanoemulsions: formation, structure and physical properties. J Phys Condens Matter 18: R635-R666.
29. Paganelli F, Cardillo JA, Dare ARJ, Chang CB, Graves SM, et al. (2010) Controlled transcleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis. Expert Opin Drug Deliv 7: 955-965.
30. Formariz TP, Chiavacci LA, Scarpa MV, Silva-Jr AA, Egito EST, et al. (2010) Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin. Colloids Surf B 77: 47-53.
31. Franzini MC, Pestana KC, Molina EF, Scarpa MV, Egito EST, et al. (2012) Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin b association. J Biomed Nanotech 8: 350-359.
32. Oliveira AG, Nothenberg MS, Cuccovia IM, Chaimovich H, (1991) Micellar catalysis of the intramolecular aminolysis of β-lactam antibiotic cephaclor. J Phys Org Chem 4: 19-24.
33. Oliveira AG, Rossanezzi G, Formariz TP, Egito EST, Scarpa MV, (2010) Effect of cationic micelles on the decomposition of α-aminophenyl cephalosporins. Colloids Surf B 79: 372-376.
34. Formariz TP, Chiavacci LA, Sarmento VHS, Franzini CM, Silva-Jr AA, et al. (2008) Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and its relationship with doxorubicin release. Colloids Surf B 63: 287-295.
35. Pestana KC, Formariz TP, Franzini CM, Sarmento VHS, Chiavacci LA, et al. (2008) Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Colloids Surf B 66: 253-259.
36. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T, (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26: 385-389.
37. Goldich Y, Marcovich AL, Barkana Y, Avni I, Zadok D, (2010) Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea 29: 409-411.
38. Kolozsvari L, Nogradi A, Hopp B, Bor Z, (2002) UV absorbance of the human cornea in the 240- to 400-nm range. Invest Ophthalmol Vis Sci 43: 2165-2168.
39. Calvo P, Vila-Jato JL, Alonso MJ, (1996) Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci 85: 530-536.
40. Ammar HO, Salama HA, Ghorab M, Mahmoud AA, (2009) Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride. AAPS Pharm SciTech 10: 808-819.
41. Badawi AA, El-Laithy HM, El Qidra RK, Mofty H, El Dally M, (2008) Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 31: 1040-1049.
42. Loch C, Zakelj S, Kristl A, Nagel S, Guthoff R, et al. (2012) Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes. Eur J Pharm Sci 47: 131-138.